Abstract:In order to test molecular models of cardiac calcium transport regulation, we have used spectroscopy to probe the structures, dynamics, and interactions of the Ca pump (Ca-ATPase) and phospholamban (PLB) in cardiac sarcoplasmic reticulum (SR) and in reconstituted membranes, Electron paramagnetic resonance (EPR) and phosphorescence of probes bound to the Ca pump show that the activity of the pump is quite sensitive to its oligomeric interactions. In cardiac SR, PLB aggregates and inhibits the pump, and both effects are reversed by PLB phosphorylation. Previous analyses of PLB's oligomeric state were only in detergent solutions, so ne used EPR and fluorescence to determine the oligomeric structure of PLB in its native state in lipid bilayers. Wild-type PLB is primarily oligomeric in the membrane, while the mutant L37A-PLB is monomeric, For both proteins, phosphorylation shifts the dynamic monomer-oligomer equilibrium toward oligomers, and induces a similar structural change, as indicated by tyrosine fluorescence; Set L37A-PLB is more effective than wild-type PLB in inhibiting and aggregating the pump. Fluorescence energy transfer shows that the Ca pump increases the fraction of monomeric PLB, indicating that the pump preferentially binds monomeric PLB. These results support a reciprocal aggregation model for Ca pump regulation, in which the Ca pump is aggregated and inhibited by association with PLB monomers, and phosphorylation of PLB reverses these effects while decreasing the concentration of PLB monomers. To investigate the structure of the PLB pentamer in more detail, we measured the reactivities of cysteine residues in the transmembrane domain of PLB, and recorded EPR spectra of spin labels attached to these sites. These results support an atomic structural model, based on molecular dynamics simulations and mutagenesis studies, in which the PLB pentamer is stabilized by a leucine-isoleucine zipper within the transmembrane domain.

ANS Interacts with the Ca2+-ATPase Nucleotide Binding Site

Allosteric modulation of the sarcoplasmic reticulum Ca 2+ ATPase by thapsigargin via decoupling of functional motions.

Interaction of Lanthanide Ions with the Sarcoplasmic Reticulum (Ca~(2+)+mg~(2+))-Atpase

Functional approach to the catalytic site of the sarcoplasmic reticulum Ca(2+)-ATPase: binding and hydrolysis of ATP in the absence of Ca(2+)

Picosecond Time-Resolved Fluorescent Spectroscopy of 1-Anilino-8-naphthalene Sulfonate Binding with Staphylococcal Nuclease in the Native and Molten Globule States.

The Structural Basis of Ca~(2+) Transport by the Ca~(2+)--ATPase from Skeletal Sarcoplasmic Reticulum

Fluorescent Analogs of NAADP with Calcium Mobilizing Activity.

Different anesthetic sensitivities of skeletal and cardiac isoforms of the Ca-ATPase

The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure

Domain Movement in Rabbit Muscle Adenylate Kinase Might Involve Proline Isomerization.

4,4 '-Dianilino-1,1 '-Binaphtliyl-5,5 '-Sulfonate, A Novel Molecule Having Chaperone-Like Activity

Dissecting the Hydrolytic Activities of Sarcoplasmic Reticulum ATPase in the Presence of Acetyl Phosphate

Ca2+ Dependent Formation/Collapse of Cylindrical Ca2+-ATPase Crystals in Scallop Sarcoplasmic Reticulum (SR) Vesicles: A Possible Dynamic Role of SR in Regulation of Muscle Contraction

Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation

Mechanistic Distinction Between Activation and Inhibition of (Na++k+)-Atpase-mediated Ca2+ Influx in Cardiomyocytes

Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban.

Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors

Probing the Anion Binding Promiscuity of the Soluble Nitrate Sensor NreA from Staphylococcus carnosus

Dynamic Binding Mode of a Synaptotagmin-1-SNARE Complex in Solution.

A network of phosphatidylinositol 4,5-bisphosphate binding sites regulates gating of the Ca2+-activated Cl- channel ANO1 (TMEM16A)

Site-Specific Antibody of (Na++k+)-Atpase Augments Cardiac Myocyte Contraction Without Inactivating Enzyme Activity